A compared with BNGO: revenue, margins and what each company keeps, and the suppliers and customers both name

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

BNGOBionano Genomics, Inc.

Mkt capRevenueRevenue

Compare

AAgilent Technologies, Inc.

BNGOBionano Genomics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+1.68%×0.22

Q2 FY26±7.7%▲+16.87%×2.19

Q1 FY26±6.4%▼−3.01%×0.47

Nov 25 '25±6.5%▲+2.34%×0.35

BNGO1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+2.59%—

= impliedA realized, solidBNGO realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

AAgilent Technologies, Inc.

174.77▲+1.74%· post 175.00

Mkt cap$49.3BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

BNGOBionano Genomics, Inc.

1.11▲+0.91%· post 1.11

ClosedNov 6 '26

Mkt cap$13.5MRevenue$8MQ2 FY26Revenue$29MFY25

Compare

ClosedNov 6 '26

AAgilent Technologies, Inc.

BNGOBionano Genomics, Inc.

174.77▲+1.74%post 175.00

Price

1.11▲+0.91%post 1.11

$49.3B

Mkt cap

$13.5M

Q3 FY26$1.9B

Revenue

$8MQ2 FY26

FY25$6.9B

Revenue

$29MFY25

A174.77▲+1.74%vsBNGO1.11▲+0.91%ClosedNov 6 '26